Roivant Sciences Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scroll to see more
Roivant Sciences Ltd. income statement - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar 2025Dec 2024Mar 2024Mar 2023Mar 2022
Revenue & Gross Profit
Revenue0.030.030.120.060.06
Cost of Revenue0.550.000.020.010.01
Gross Profit-0.520.030.110.050.05
Operating Expenses
Research & Development0.550.550.500.530.48
Selling, General & Administrative0.570.590.690.600.78
Operating Expenses0.571.031.231.241.41
Operating Income-1.09-1.004.24-1.18-1.35
Other Income/Expense
Interest Income0.260.260.030.000.00
Interest Expense0.000.000.03-0.010.00
Other Income/Expense0.010.320.02-0.150.29
Income
Income Before Tax-0.68-0.684.25-1.22-0.92
Income Tax Expense0.050.050.020.010.00
Net Income-0.17-0.174.35-1.01-0.85
Net Income - Continuous Operations-0.73-0.17-0.89-0.920.00
Net Income - Discontinued Operations0.37-0.32-0.230.000.00
EBITDA-1.07-1.104.31-1.01-0.91
EBIT-1.09-0.824.29-1.04-0.92
Depreciation & Amortization0.010.010.020.010.00
Earnings Per Share
Basic EPS--6.00-3.00-1.00
Diluted EPS--5.00-3.00-1.00
Basic Shares Outstanding0.730.730.780.710.67
Diluted Shares Outstanding0.730.730.830.710.67